
What they do:
Unlocking the power of biotech with modern software for modern science
Quick facts:
HQ: San Francisco, CA, United States
This list has 524 startups and was last updated on Oct 15, 2026. 37 of them are hiring right now. Biggest hubs: San Francisco (134), Boston (35), and New York (27). Largest teams: Benchling, Ginkgo Bioworks, and BillionToOne. Latest round: Renue Life Sciences raised $250K (Oct 14, 2026).
Survival statistics →91 open roles →

What they do:
Unlocking the power of biotech with modern software for modern science
Quick facts:
HQ: San Francisco, CA, United States

What they do:
Our mission is to make biology easier to engineer.
Quick facts:
HQ: Boston, MA, United States

What they do:
Personalized drug discovery for blood cancer.
Quick facts:
HQ: San Francisco, CA, United States

What they do:
We break viruses
Quick facts:
HQ: San Francisco, CA, United States

What they do:
The genetic testing platform detecting and measuring disease.
Quick facts:
HQ: San Francisco, CA, United States

What they do:
We make robots for biologists.
Quick facts:
HQ: New York, NY, United States

What they do:
Decarbonizing the chemicals industry.
Quick facts:
HQ: Houston, TX, United States

What they do:
Artificial intelligence for drug discovery.
Quick facts:
HQ: San Francisco, CA, United States
Funding:
$19.8M · Equity · Mar 2026

What they do:
Unleash the potential of genomic medicine using AI
Quick facts:
Funding:
€23.2M · Series B · Oct 2026

What they do:
Breye Therapeutics (Breye), a Danish clinical-stage biopharmaceutical company developing oral therapeutics for the early treatment of retinal diseases, has closed an oversubscribed €67.5 million Series A financing…
Quick facts:
HQ: Denmark
Funding:
€67.5M · Series A · Oct 2026

What they do:
Altay develops disease-modifying therapies targeting transcription…
Quick facts:
HQ: San Francisco, CA, United States
Funding:
$15.7M · Equity · Oct 2026

What they do:
AMilan-based biotech company developing novel treatments for difficult to treat genetic conditions has raised a $45m seed round, it said today.Theseed round investment in Aptadir Therapeutics is one o...
Quick facts:
Funding:
$45M · Seed · Sep 2026
What they do:
Austin-based Tiny Health has raised $33 million in a Series B funding round led by B Capital to help it meet growing demand for its at-home microbiome tests.
Quick facts:
Funding:
$33M · Series B · Sep 2026
What they do:
An MRI in late 2023 found a mass on Matthew Osman's pancreas. It turned out to be benign, but the months of not knowing made him ask why medicine still cannot predict what happens inside the human body. Today, his…
Quick facts:
Funding:
$20M · Oct 2026
What they do:
Cambridge-based Undecimal Bio, a spin-out from Eleven Therapeutics advancing targeted delivery of siRNA therapeutics, today announced a €16 million ($18 million) Seed financing round to expand DELiveri, its…
Quick facts:
HQ: United Kingdom
Funding:
€16M · Seed · Oct 2026

What they do:
AI drug discovery platform for neurotherapeutics
Quick facts:
HQ: San Francisco, CA, United States
Funding:
$2.16M · Options · Feb 2026

What they do:
Next-generation DNA synthesis using enzymes
Quick facts:
HQ: San Francisco, CA, United States

What they do:
A nonprofit stool bank enabling access to fecal transplants.
Quick facts:
HQ: Boston, MA, United States
What they do:
As many as 1 in 3 urine cultures come back negative, yet the burning and urgency keep coming. A Cornell Tech spinout says the infection is often still there: in a study of 200+ culture-negative samples, its…
Quick facts:
Funding:
$9M · Oct 2026

What they do:
Cori Clinical, a London-based startup that acts as the intelligence layer to accelerate clinical trials, has closed a €3.8 million Seed round led by Breega, with participation from Enzo, Heartfelt, Together Ventures,…
Quick facts:
HQ: London, United Kingdom
Funding:
€3.8M · Seed · Oct 2026

What they do:
Omnio, a Umeå-based BioTech startup, has raised an oversubscribed €2.9 million round from existing investors and shareholders to advance its plasminogen-based therapy for hard-to-heal chronic wounds toward clinical…
Quick facts:
HQ: Sweden
Funding:
€2.9M · Oct 2026

What they do:
We use human data and AI to develop better drugs faster.
Quick facts:
HQ: San Francisco, CA, United States
What they do:
Lygos (W16) built and commercialized sustainable, high-performance…
Quick facts:
HQ: San Francisco, CA, United States

What they do:
Unlocking the utility of genomics for the world.
Quick facts:
HQ: Boston, MA, United States

What they do:
Unlocking the next generation of mRNA medicines
Quick facts:
HQ: Oxford, United Kingdom

What they do:
Foundation models and autonomous chambers for plant biology
Quick facts:

What they do:
Discovering the true signals of disease to power life-changing drugs.
Quick facts:
HQ: St. John's, Canada

What they do:
RNA medicines for liver diseases
Quick facts:
HQ: London, United Kingdom

What they do:
Medicinal Chemistry powered by Machine Learning
Quick facts:
HQ: Boston, MA, United States

What they do:
maximizing biomass on low quality land
Quick facts:
HQ: San Francisco, CA, United States

What they do:
We grow cells for biotech companies.
Quick facts:
HQ: San Francisco, CA, United States

What they do:
Robots that automate the everyday tasks of microbiologists.
Quick facts:
HQ: Copenhagen, Denmark

What they do:
Next-gen ingredients to decarbonize consumer products, starting w/…
Quick facts:
HQ: New York, NY, United States

What they do:
We make unmakeable proteins with radical advanced biomanufacturing.
Quick facts:
HQ: Edmonton, Canada

What they do:
Agentic AI platform for Pharma GTM teams
Quick facts:
HQ: San Francisco, CA, United States

What they do:
Robotic human cell manufacturing
Quick facts:
HQ: London, United Kingdom
There are 524 startups on this list, last updated on Oct 15, 2026.
37 of them are hiring right now, including Ginkgo Bioworks, Notable Labs, and BillionToOne.
By team size: Benchling (750 employees), Ginkgo Bioworks (641 employees), and BillionToOne (300 employees).
Latest rounds: Renue Life Sciences — $250K (Oct 2026), Myris Therapeutics — $500K Debt (Oct 2026), and Kaigene — $55M Equity (Oct 2026).
The biggest hubs are San Francisco (134), Boston (35), and New York (27).